Understanding DIPK1B: A Potential Drug Target (G138311)

Target Name: DIPK1B

NCBI ID: G138311

DIPK1B

Understanding DIPK1B: A Potential Drug Target

DIPK1B, also known as divergent protein kinase domain 1B, is a protein that plays a crucial role in various cellular processes. It is a key regulator of cell proliferation, differentiation, and survival, and is involved in the development and progression of many diseases. As a result, DIPK1B has become an attractive drug target and a focus of intense research in the scientific community.

DIPK1B is a protein that is found in many different cell types, including neurons, muscle cells, and cancer cells. It is a member of the protein kinase family, which is a large and diverse family of enzymes that play a critical role in cellular signaling . The protein encoded by the DIPK1B gene is a 21-kDa protein that contains a unique kinase domain that is characterized by a specific arrangement of amino acids.

The DIPK1B kinase domain is responsible for the protein's catalytic activity. It consists of a highly conserved catalytic core that is surrounded by a variable region that is responsible for the protein's specificity and interactions with other proteins. The catalytic core of DIPK1B is composed of a unique Arrangement of amino acids that is highly conserved across different species, and is known as the \"DIPK1B consensus sequence.\" This sequence is thought to be critical for the protein's catalytic activity and stability.

In addition to its catalytic activity, DIPK1B also has several unique features that make it a potential drug target. For example, it is a protein that is highly transmembrane, meaning that it is able to span the cell membrane and interact with various cells surface molecules. This allows it to be easily targeted by small molecules, such as drugs, and also allows it to act as a biomarker for the treatment of certain diseases.

DIPK1B is also involved in several cellular processes that are critical for the development and progression of many diseases. For example, it is involved in the regulation of cell proliferation, and is thought to play a role in the development of cancer. It is also involved in the regulation of cell differentiation and plasticity, and is thought to play a role in the development of neurodegenerative diseases. In addition, DIPK1B is involved in the regulation of cell survival, and is thought to play a role in the development of neuroprotective drugs.

Despite its potential as a drug target, DIPK1B is still an poorly understood protein. Only a few studies have been conducted to investigate its role in cellular signaling, and there is a lack of information about its specific mechanisms of action. As a result, there is a need for further research to be conducted in order to fully understand the potential of DIPK1B as a drug target.

In conclusion, DIPK1B is a protein that is highly conserved across different species and is involved in various cellular processes that are critical for the development and progression of many diseases. As a result, it has become an attractive drug target and a focus of intense research in the scientific community. Further research is needed in order to fully understand its role in cellular signaling and its potential as a drug target.

Protein Name: Divergent Protein Kinase Domain 1B

The "DIPK1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DIPK1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets